发明名称 COMPOUNDS USEFUL AS MODULATORS OF MELANOCORTIN RECEPTORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
摘要 Compounds having the formula (I), and pharmaceutically-acceptable salts, hydrates and prodrugs thereof, in which E is formula (II), X is N or CH, W is -NR>16<R>17<, -NR>16<C(=O)R>22<, -NR>16<CO>2<R>22<, -OR>23<, or a heteroaryl or heterocyclo group as defined in the specification, and R>1< through R>12<, R>16<, R>17<, R>22<, R>23<, x, y, and z are as defined in the specification, are useful as modulators of melanocortin receptors, particularly MC-1R and MC-4R.
申请公布号 WO02079146(A2) 申请公布日期 2002.10.10
申请号 WO2002US06581 申请日期 2002.03.02
申请人 BRISTOL-MYERS SQUIBB COMPANY;YU, GUIXUE;MACOR, JOHN;HERPIN, TIMOTHY;LAWRENCE, R, MICHAEL;MORTON, GEORGE, C;RUEL, REJEAN;POINDEXTER, GRAHAM, S;RUEDIGER, EDWARD, H;THIBAULT, CARL 发明人 YU, GUIXUE;MACOR, JOHN;HERPIN, TIMOTHY;LAWRENCE, R, MICHAEL;MORTON, GEORGE, C;RUEL, REJEAN;POINDEXTER, GRAHAM, S;RUEDIGER, EDWARD, H;THIBAULT, CARL
分类号 C07D233/64;A61K31/4178;A61K31/438;A61K31/451;A61K31/454;A61K31/4545;A61K31/47;A61K31/4709;A61K31/4725;A61K31/4747;A61K31/496;A61K31/501;A61K31/506;A61K31/519;A61K31/527;A61K31/537;A61K31/5377;A61K31/5415;A61K31/55;A61K38/00;A61P1/00;A61P1/04;A61P1/16;A61P1/18;A61P3/02;A61P3/04;A61P3/06;A61P3/10;A61P5/14;A61P5/16;A61P7/00;A61P7/02;A61P9/00;A61P9/04;A61P9/10;A61P9/12;A61P11/00;A61P11/02;A61P11/06;A61P11/08;A61P13/12;A61P15/00;A61P15/08;A61P15/10;A61P17/00;A61P17/04;A61P17/06;A61P17/14;A61P17/16;A61P19/02;A61P19/10;A61P21/00;A61P25/00;A61P25/02;A61P25/04;A61P25/06;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P27/16;A61P29/00;A61P31/04;A61P31/06;A61P31/18;A61P31/20;A61P33/06;A61P35/00;A61P37/06;A61P37/08;A61P43/00;C07D211/32;C07D211/34;C07D211/58;C07D211/60;C07D211/62;C07D401/04;C07D401/06;C07D401/12;C07D401/14;C07D403/12;C07D405/14;C07D409/14;C07D413/12;C07D413/14;C07D417/12;C07D417/14;C07D471/10;C07D487/04;C07D491/10;C07D495/04;C07D498/10;C07K5/06;C07K5/078 主分类号 C07D233/64
代理机构 代理人
主权项
地址